Investing
717 Articles
A US drug advisory panel today denied by a 12-1 vote permission for Amgen Inc. (NASDAQ: AMGN) to market its…
Credit Suisse is making a change in its Global Biotechnology outlook and says the is ‘room to run on generalist…
All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…
Thursday brought yet more merger and acquisition news in the ongoing buyout trends in the biotech sector. Amgen Inc. (NASDAQ: AMGN)…
Equity markets opened slightly higher this morning but trailed off to negative territory in the late morning. By late afternoon,…
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…
US equity markets opened sharply higher this morning and have been able to sustain and even add to those gains…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage research calls this…
US equity markets opened solidly higher this morning, but began to lose momentum by mid-morning. From there it’s been a…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning.…
Stocks opened a bit lower this morning, but almost immediately turned around without being able to break through the opening…
Our top personal finance-related articles today. Your wallet will thank you later.